This indicates that mTOR participates in and regulates ROS-mediated ERS-related CD4+ T cell apoptosis in sepsis, raising the possibility of mTOR becoming a new targeted treatment strategy for alleviating CD4+ T cell apoptosis and improving the immune status of those experiencing sepsis. Here, CD4 is linked to Sepsis.